Gynecological and reproductive factors and the risk of pancreatic cancer: A case-control study.

Published on Jul 31, 2020in Pancreatology3.629
· DOI :10.1016/J.PAN.2020.07.398
Livia Archibugi13
Estimated H-index: 13
(Sapienza University of Rome),
Benedetta Graglia1
Estimated H-index: 1
(Sapienza University of Rome)
+ 6 AuthorsGabriele Capurso56
Estimated H-index: 56
(UniSR: Vita-Salute San Raffaele University)
Sources
Abstract
Abstract Background /Objectives: Pancreatic ductal adenocarcinoma (PDAC) has a higher incidence in men compared to women, although the difference in known risk factors cannot explain this disparity completely. Reproductive and hormonal factors have been demonstrated in pre-clinical studies to influence pancreatic carcinogenesis, but the few published data on the topic are inconsistent. The aim was to investigate the role of reproductive and hormonal factors on PDAC occurrence in women. Methods We conducted a unicenter case-control study; PDAC cases were matched to controls by age with a 1:2 ratio. Risk factors were screened through questionnaires about gynecologic and medical history. Comparisons were made using Chi-square and Fisher's exact tests where appropriate for categorical variables and Student's t-test for continuous variables. Logistic regression was used to calculate Odds Ratios (ORs) and their 95% confidence intervals (CI). Multivariable logistic regression models were adjusted for potential confounders. Results 253 PDAC and 506 matched controls were enrolled. At logistic regression multivariable analysis adjusted for confounding factors, older age at menopause (OR:0.95 per year; 95% CI:0.91–0.98; p = 0.007), use of Oral Contraceptives (OR:0.52; 95% CI:0.30–0.89; p = 0.018), use of Hormonal Replacement Therapy (OR:0.31; 95% CI:0.15–0.64; p = 0.001), and having had two children (OR:0.57; 95% CI:0.38–0.84; p = 0.005) were significant, independent protective factors for the onset of PDAC. Conclusions These data confirm some previous findings on menopause age and number of births while, to our knowledge, this is the first study to show a protective effect of HRT and OC use. The results collectively support the hypothesis that exposure to estrogens plays a protective role towards PDAC.
📖 Papers frequently viewed together
60 Citations
20103.31Menopause
5 Authors (Franco Lumachi, ..., Mario Ermani)
10 Citations
19 Citations
References42
Newest
#1Elena C. Tore (University of Birmingham)H-Index: 1
#2Evangelia Antoniou (PHRI: Public Health Research Institute)H-Index: 3
Last. Maurice P. Zeegers (UM: Maastricht University)H-Index: 67
view all 13 authors...
OBJECTIVES Maternal pre-pregnancy weight is known to affect foetal development. However, it has not yet been clarified if gestational weight gain is associated with childhood behavioural development. METHODS We performed a pooled analysis of two prospective birth cohorts to investigate the association between gestational weight gain and childhood problem behaviours, and the effect modification of maternal pre-pregnancy BMI. In total, 378 mother-child pairs from the Maastricht Essential Fatty Aci...
2 CitationsSource
#1Zhirong Miao (PKU: Peking University)H-Index: 1
#2Honghua Wu (PKU: Peking University)H-Index: 2
Last. Xiaohui Guo (PKU: Peking University)H-Index: 24
view all 8 authors...
Aims: The objective of the present study was to explore the long-term postpartum glucose metabolism in women with previous GDM, and study the mechanism of hyperglycemia from gestation to postpartum by investigating the postpartum insulin resistance and insulin secretion. Methods: A total of 321 females with previous GDM were followed up once during 1- to 6-years postpartum. Characteristics during pregnancy, perinatal period, and postpartum were compared between postpartum NGT and hyperglycemic w...
6 CitationsSource
BackgroundMost pancreatic ductal adenocarcinoma patients present with advanced disease. Whether it is possible to increase survival by earlier diagnosis is unclear.ObjectiveThe purpose of this stud...
8 CitationsSource
#1Tamás Deli (University of Debrecen)H-Index: 8
#2Mónika Orosz (University of Debrecen)H-Index: 1
Last. Attila Jakab (University of Debrecen)H-Index: 14
view all 3 authors...
Rapid advance in oncology leads to increasing survival of oncologic patients. More and more of them live long enough to reach either the natural age of menopause or, as a side effect of their oncotherapy, experience the cessation of gonadal function, leading to premature ovarian insufficiency, with disturbing vasomotor symtoms and long-term negative cardiovascular and skeletal effects. Thus, an ever increasing number of cancer survivors search endocrinologic help in the form of hormone replaceme...
31 CitationsSource
#1Salvatore Paiella (University of Verona)H-Index: 23
#2Gabriele CapursoH-Index: 56
Last. Alessandro ZerbiH-Index: 57
view all 19 authors...
Surveillance programs on high-risk individuals (HRIs) can detect pre-malignant lesions or early pancreatic cancer (PC). We report the results of the first screening round of the Italian multicenter program supported by the Italian Association for the study of the Pancreas (AISP). The multicenter surveillance program included asymptomatic HRIs with familial (FPC) or genetic frailty (GS: BRCA1/2, p16/CDKN2A, STK11/LKB1or PRSS1, mutated genes) predisposition to PC. The surveillance program included...
20 CitationsSource
#1Livia Archibugi (UniSR: Vita-Salute San Raffaele University)H-Index: 13
#2Paolo Giorgio Arcidiacono (UniSR: Vita-Salute San Raffaele University)H-Index: 40
Last. Gabriele Capurso (UniSR: Vita-Salute San Raffaele University)H-Index: 56
view all 3 authors...
Abstract Background Previous studies investigating the association between statin use and pancreatic cancer (PDAC) risk for a possible chemopreventive effect gathered heterogeneous results. Aims To conduct a systematic review and meta-analysis to clarify this association. Methods Comprehensive literature search of articles published up to February 2018, including case-control (CC),cohort studies (C), randomized controlled trials (RCTs) assessing association between statin use and PDAC risk. Stud...
19 CitationsSource
#1Mamoun Younes (University of Texas Health Science Center at Houston)H-Index: 47
#2Charles J Ly (University of Texas Health Science Center at Houston)H-Index: 1
Last. Jennifer M. Bailey (University of Texas Health Science Center at Houston)H-Index: 20
view all 6 authors...
// Mamoun Younes 1 , Charles J. Ly 1 , Kanchan Singh 2 , Atilla Ertan 2 , Pamela S. Younes 1 and Jennifer M. Bailey 2 1 Departments of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA 2 Department of Medicine, Section of Gastroenterology, Hepatology and Nutrition, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA Correspondence to: Mamoun Younes, email: mamoun.younes@uth....
2 CitationsSource
#1Sedrah Arif Butt (Copenhagen University Hospital)H-Index: 1
#3Charlotte Wessel Skovlund (UCPH: University of Copenhagen)H-Index: 14
Last. Shona FieldingH-Index: 25
view all 7 authors...
Importance The association between the use of hormonal contraceptive and pancreatic cancer among premenopausal women has until now been unclear. This is the first study to investigate the risk of pancreatic cancer in pre-menopausal women. Objective To determine whether hormonal contraception increases the risk of developing pancreatic cancer in pre-menopausal women. Design A nationwide prospective cohort study followed all women in Denmark in the age range of 15–49 years without previous cancer ...
5 CitationsSource
#1Kara A. Michels (NIH: National Institutes of Health)H-Index: 11
#2Louise A. Brinton (NIH: National Institutes of Health)H-Index: 141
Last. Britton Trabert (NIH: National Institutes of Health)H-Index: 38
view all 4 authors...
: Although use of oral contraceptives (OCs) is common, their influence on carcinogenesis is not fully understood. We used Cox proportional hazards models to examine OC use (never/<1 year (referent), 1-4, 5-9, ≥10 years) and development of incident cancers across body sites within the same base population: women in the prospective National Institutes of Health-AARP Diet and Health Study (enrolled 1995-1996 and followed until 2011). Adjustment for confounding varied by outcome; all models accounte...
14 CitationsSource
#1Ioannis Pozios (Charité)H-Index: 3
#2Thomas Knösel (LMU: Ludwig Maximilian University of Munich)H-Index: 34
Last. Hendrik Seeliger (Charité)H-Index: 19
view all 9 authors...
Purpose The role of estrogen receptor beta (ER-β) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Ligand-independent phosphorylation and activation of ER-β may play a relevant role in the IL-6/STAT3 signaling pathway and, as a result, in tumor progression. Here, we examined the effect of ER-β, phosphorylated ER-β (pER-β), STAT3, phosphorylated STAT3 (pSTAT3) and IL-6 expression on the overall and recurrence-free survival in a cohort of patients with resected PDAC.
10 CitationsSource
Cited By1
Newest
#1Milena IlicH-Index: 4
#2Biljana Milicic (University of Belgrade)H-Index: 12
Last. Irena IlicH-Index: 9
view all 3 authors...
Source